About NanoTx Therapeutics
NanoTx Therapeutics is a Healthcare company based in San Antonio (United States) founded in 2014. Radioactive liposomes for glioblastoma treatment are developed. It operates in the Healthcare and Technology sectors. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its competitors include C4 Therapeutics, Erasca and Revolution Medicines; 3 of its 3 listed competitors have raised funding.
Company details
NanoTx Therapeutics was founded in 2014 in San Antonio, United States, within the biotechnology sector focused on oncology. Radioactive liposomes are developed for glioblastoma, a type of brain cancer. The lead candidate, Rhenium 186, is advanced in Phase 1 clinical trials. Direct delivery to the tumor site is achieved through a proprietary catheter. Operations center on innovative drug delivery methods for targeted cancer therapies.
- Headquarters San Antonio, United States
- SectorsHealthcareTechnology
- Email••••••••
- Website nano-tx.com
- Latest Funding Round$2M (USD), Grant
Feb 2015
- Investors
Funding Insights of NanoTx Therapeutics
- Total Rounds 1
- Last Round Grant — $2M
- First Round $2M
(Feb 2015)
- Investors Count 1
All 1 funding rounds of NanoTx Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2015 | $2M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in NanoTx Therapeutics
NanoTx Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CPRIT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| cprit.texas.gov |
Investor details for NanoTx Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NanoTx Therapeutics
2 dated milestones of NanoTx Therapeutics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded NanoTx Therapeutics is founded.
- Funding First funding round of $2.0M.
Competitors of NanoTx Therapeutics
NanoTx Therapeutics has 3 listed competitors in our database, 3 of them funded. They include C4 Therapeutics, Erasca and Revolution Medicines.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. | |
| erasca.com | 2018 | San Diego, United States | $300M | 120 | Small molecule therapeutics for cancer treatment are developed. | |
| revmed.com | 2014 | Redwood, United States | $326.29M | 181 | Cancer therapies are developed using selective pathway inhibitors. |
Detailed competitors of NanoTx Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as NanoTx Therapeutics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NanoTx Therapeutics
NanoTx Therapeutics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
NanoTx Therapeutics is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
NanoTx Therapeutics was founded in 2014 in San Antonio, United States, within the biotechnology sector focused on oncology. Radioactive liposomes are developed for glioblastoma, a type of brain cancer. The lead candidate, Rhenium 186, is advanced in Phase 1 clinical trials. Direct delivery to the tumor site is achieved through a proprietary catheter. Operations center on innovative drug delivery methods for targeted cancer therapies.
NanoTx Therapeutics's top competitors include C4 Therapeutics, Erasca and Revolution Medicines.
NanoTx Therapeutics has 1 investor. Key investors include CPRIT.